{"id":"W2124443610","doi":"10.1634/theoncologist.10-10-780","title":"Adjuvant Chemotherapy for Early Breast Cancer: Optimal Use of Epirubicin","year":2005,"lang":"en","type":"review","venue":"The Oncologist","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Epirubicin; Medicine; Trastuzumab; Breast cancer; Oncology; Cardiotoxicity; Adjuvant; Anthracycline; Internal medicine; Chemotherapy; Doxorubicin; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001642814,0.0004297863,0.001195243,0.00003454454,0.0001104335,0.00001779513,0.000433426,0.0003192271,0.00002930775],"category_scores_gemma":[0.00003045491,0.000256741,0.0005706974,0.00009888106,0.0003909548,0.000003479556,0.0001470603,0.0001310452,0.000006047222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001594684,"about_ca_system_score_gemma":0.0003684804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004898005,"about_ca_topic_score_gemma":0.0002219025,"domain_scores_codex":[0.9985715,0.0001013969,0.0004404231,0.0004405916,0.0001126803,0.0003334491],"domain_scores_gemma":[0.9986151,0.0001308645,0.0005049316,0.0005837677,0.0001183164,0.00004703973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002177362,0.0001317481,0.00006881282,0.0006355054,0.0008039755,0.000001067895,0.0000298765,0.00001656848,0.00002125457,0.00001871367,0.006546022,0.9915087],"study_design_scores_gemma":[0.0006807274,0.0002666237,0.0006350703,0.000708468,0.0008668666,0.00004032631,0.00001022612,0.000001325563,0.00008331249,0.000002635433,0.9964371,0.0002673029],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003503589,0.9954965,0.00006940696,0.0005889528,0.0001992364,0.001146675,0.002049577,0.00001545292,0.00008380183],"genre_scores_gemma":[0.0004436886,0.9957371,0.0006906916,0.0002006742,0.0009798161,0.0008275426,0.0002043119,0.00007142198,0.0008447234],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912414,"threshold_uncertainty_score":0.9999885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0729664907286145,"score_gpt":0.3820396497003825,"score_spread":0.309073158971768,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}